# EDGAR Filing Document

**Accession Number:** 0001833141
**File Stem:** 0001628280-23-006115
**Filing Date:** 2023-3
**Character Count:** 8238
**Document Hash:** 417cb0f1144456dc381059a8531ec806
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-23-006115.hdr.sgml**: 20230302

**ACCESSION NUMBER**: 0001628280-23-006115

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230302

**FILED AS OF DATE**: 20230302

**DATE AS OF CHANGE**: 20230302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CYBIN INC.
- **CENTRAL INDEX KEY:** 0001833141
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40673
- **FILM NUMBER:** 23700431

**BUSINESS ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9
- **BUSINESS PHONE:** (908) 764-8385

**MAIL ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9

**UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION**<br>**Washington, D.C. 20549**<br>**Form 6-K**<br>**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>UNDER THE SECURITIES EXCHANGE ACT OF 1934**<br>

For the month of March, 2023.

Commission File Number: **001-40673**

****<br>**<u>Cybin Inc.</u>**<br>(Exact Name of Registrant as Specified in Charter)<br>**100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9** 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F □ Form 40-F ⊠

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

**Note**: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

**Note**: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br>

---

| | | | |
|:---|:---|:---|:---|
| | | **CYBIN INC.** | **CYBIN INC.** |
| | | (Registrant) | (Registrant) |
| Date: | March 2, 2023 | By: | */s/ Doug Drysdale&nbsp;&nbsp;&nbsp;&nbsp;*  |
|  |  | Name: | Doug Drysdale |
|  |  | Title: | Chief Executive Officer |

---

------

**<u>EXHIBIT INDEX</u>**

99.1 <u>[News Release dated March 2, 2023](cybnsouthbysouthwestprfinal.htm)</u>

## Exhibit 99.1

**Cybin and The Chopra Foundation to Participate in Featured Session at Upcoming 2023 South by Southwest**<sup>®</sup> **Conference**<br>

*- Cybin CEO, Doug Drysdale and Wellness Icon Deepak Chopra to be featured on panel titled Open Minds: Innovations in Consciousness, Psychedelics & Mental Health-*

<br>March 2, 2023 – <u>Cybin Inc.</u> (NEO:CYBN) (NYSE American:CYBN) ("**Cybin**" or the "**Company**"), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics<sup>®</sup> and The Chopra Foundation, a not-for-profit organization dedicated to improving health and well-being founded by Dr. Deepak Chopra, are pleased to announce that Dr. Chopra and Chief Executive Officer of Cybin, Doug Drysdale will be featured on a panel at the upcoming South by Southwest<sup>®</sup> (SXSW<sup>®</sup>) Conference taking place in Austin, TX March 10 – 19, 2023. The panel titled, *Open Minds: Innovations in Consciousness, Psychedelics & Mental Health*, will be held on Sunday, March 12, 2023 at 11:30am CT at the Austin Convention Center. For more information on SXSW and the featured panel, please <u>click here</u>.

Psychedelic-based therapies continue to influence the evolving landscape of mental health. As humanity begins to understand the complexity of consciousness and its impact on mental health, these worlds will become increasingly intertwined. In the featured SXSW panel session, Dr. Chopra, Mr. Drysdale and guests, including Cristie Strongman MA, Ed.M., Psychotherapist at the Multidisciplinary Association for Psychedelic Studies (MAPS) and Gabriella Wright, actress, activist, and co-founder of the Never Alone Alliance, will discuss and explore the connection between consciousness, mental health, and psychedelic therapeutics and the need for humanity to focus on the internal work required to heal.

These leading industry experts are also featured in the upcoming six-part miniseries *Open Minds: Exploring Psychedelic Medicine* that addresses the topics of consciousness, the experience of using psychedelic treatments, the current research landscape and what the future of mental healthcare may look like. The miniseries also features researcher Dennis McKenna, who has conducted interdisciplinary research on the ethnopharmacology of Amazonian traditional medicines for over 40 years, Bryan Johnson, Founder and CEO of Kernel, Keith Ferrazzi, Founder and Chairman of Ferrazzi Greenlight, and Adam Strauss, comedian and psychedelic advocate.

*Open Minds* is produced by the progressive streaming network <u>ALTRD.TV</u>. ALTRD is home to feature films, documentaries, and original TV series focused on disruptive markets and the modern counterculture. *Open Minds* will be released on April 19, 2023 on all smart devices everywhere and at <u>www.altrd.tv</u>. For more information on *Open Minds* please visit <u>https://www.thefutureofpsychedelictherapy.com/</u>.&nbsp;&nbsp;&nbsp;&nbsp;

------

**About ALTRD.TV**

ALTRD TV is the streaming network for progressive culture featuring content from top creators in web3, transformative wellness, NFTs and animation, and more. Audiences can watch thousands of free and unlimited features, docs, and series on smart devices and TVs in 65M+ homes, on networks including AppleTV/ios, Android, Samsung+, Plex, Roku, LG, and Playstation.

**ALTRD.TV Contact:** 

Joshua Otten<br>Co-Founder and CEO<br>info@ronincontent.com

**About Cybin**

Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.

**Cybin Contacts:** 

Leah Gibson

Vice President, Investor Relations & Strategic Communications

Cybin Inc.

leah@cybin.com

Gabriel Fahel

Chief Legal Officer

Cybin Inc.

1-866-292-4601

**About The Chopra Foundation and Never Alone Alliance**

The Chopra Foundation is a 501 (c) (3) organization (#36-4793898) dedicated to improving health and well-being, cultivating spiritual knowledge, expanding consciousness, and promoting world peace to all members of the human family. The Foundation's Never Alone movement will be providing the world with the tools to proactively pursue their path to joy and freedom from suffering.

**Media Inquiries:**

Kristen Marion

kristen@marionpr.com

------

623-308-2638